-
1
-
-
84860467522
-
Effects of regular aspirin on long-term cancer incidence and metastasis: A systematic comparison of evidence from observational studies versus randomised trials
-
Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012;13(5):518-527.
-
(2012)
Lancet Oncol.
, vol.13
, Issue.5
, pp. 518-527
-
-
Algra, A.M.1
Rothwell, P.M.2
-
2
-
-
68849123400
-
Aspirin use and survival after diagnosis of colorectal cancer
-
Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA. 2009;302(6):649-658.
-
(2009)
JAMA
, vol.302
, Issue.6
, pp. 649-658
-
-
Chan, A.T.1
Ogino, S.2
Fuchs, C.S.3
-
3
-
-
80053994835
-
Aspirin and cancer: Has aspirin been overlooked as an adjuvant therapy?
-
Langley RE, Burdett S, Tierney JF, Cafferty F, Parmar MK, Venning G. Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy? Br J Cancer. 2011;105(8):1107-1113.
-
(2011)
Br J Cancer
, vol.105
, Issue.8
, pp. 1107-1113
-
-
Langley, R.E.1
Burdett, S.2
Tierney, J.F.3
Cafferty, F.4
Parmar, M.K.5
Venning, G.6
-
4
-
-
84874938572
-
Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality
-
McCowan C, Munro AJ, Donnan PT, Steele RJ. Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality. Eur J Cancer. 2013;49(5):1049-1057.
-
(2013)
Eur J Cancer.
, vol.49
, Issue.5
, pp. 1049-1057
-
-
McCowan, C.1
Munro, A.J.2
Donnan, P.T.3
Steele, R.J.4
-
5
-
-
78650215449
-
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
-
Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376(9754):1741-1750.
-
(2010)
Lancet.
, vol.376
, Issue.9754
, pp. 1741-1750
-
-
Rothwell, P.M.1
Wilson, M.2
Elwin, C.E.3
-
6
-
-
78650825618
-
Effect of daily aspirin on long-term risk of death due to cancer: Analysis of individual patient data from randomised trials
-
Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011;377(9759):31-41.
-
(2011)
Lancet.
, vol.377
, Issue.9759
, pp. 31-41
-
-
Rothwell, P.M.1
Fowkes, F.G.2
Belch, J.F.3
Ogawa, H.4
Warlow, C.P.5
Meade, T.W.6
-
7
-
-
84863399038
-
Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomised controlled trials
-
Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet. 2012;379(9826):1591-1601.
-
(2012)
Lancet.
, vol.379
, Issue.9826
, pp. 1591-1601
-
-
Rothwell, P.M.1
Wilson, M.2
Price, J.F.3
Belch, J.F.4
Meade, T.W.5
Mehta, Z.6
-
8
-
-
84860250352
-
Use of aspirin postdiagnosis improves survival for colon cancer patients
-
Bastiaannet E, Sampieri K, Dekkers OM, et al. Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer. 2012;106(9):1564-1570.
-
(2012)
Br J Cancer.
, vol.106
, Issue.9
, pp. 1564-1570
-
-
Bastiaannet, E.1
Sampieri, K.2
Dekkers, O.M.3
-
9
-
-
84867101876
-
Aspirin as adjuvant therapy for colorectal cancer - Reinterpreting paradigms
-
Chia WK, Ali R, Toh HC. Aspirin as adjuvant therapy for colorectal cancer - reinterpreting paradigms. Nat Rev Clin Oncol. 2012;9(10):561-570.
-
(2012)
Nat Rev Clin Oncol.
, vol.9
, Issue.10
, pp. 561-570
-
-
Chia, W.K.1
Ali, R.2
Toh, H.C.3
-
10
-
-
84871027434
-
Aspirin use after diagnosis improves survival in older adults with colon cancer: A retrospective cohort study
-
ReimersMS, Bastiaannet E, van Herk-Sukel MP, et al. Aspirin use after diagnosis improves survival in older adults with colon cancer: a retrospective cohort study. J AmGeriatr Soc. 2012;60(12):2232-2236.
-
(2012)
J AmGeriatr Soc.
, vol.60
, Issue.12
, pp. 2232-2236
-
-
Reimers, M.S.1
Bastiaannet, E.2
Van Herk-Sukel, M.P.3
-
11
-
-
20144388469
-
Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis
-
DongM, Johnson M, Rezaie A, et al. Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis. Clin Cancer Res. 2005;11(6):2265-2271.
-
(2005)
Clin Cancer Res.
, vol.11
, Issue.6
, pp. 2265-2271
-
-
Dong, M.1
Johnson, M.2
Rezaie, A.3
-
12
-
-
11144224065
-
Cyclooxygenase-2 expression: A significant prognostic indicator for patients with colorectal cancer
-
Soumaoro LT, Uetake H, Higuchi T, Takagi Y, EnomotoM, Sugihara K. Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res. 2004;10(24):8465-8471.
-
(2004)
Clin Cancer Res.
, vol.10
, Issue.24
, pp. 8465-8471
-
-
Soumaoro, L.T.1
Uetake, H.2
Higuchi, T.3
Takagi, Y.4
Enomoto, M.5
Sugihara, K.6
-
15
-
-
0020692577
-
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man
-
FitzGerald GA, Oates JA, Hawiger J, et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest. 1983;71(3):676-688.
-
(1983)
J Clin Invest.
, vol.71
, Issue.3
, pp. 676-688
-
-
Fitzgerald, G.A.1
Oates, J.A.2
Hawiger, J.3
-
16
-
-
0019988413
-
Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects
-
Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest. 1982;69(6):1366-1372.
-
(1982)
J Clin Invest.
, vol.69
, Issue.6
, pp. 1366-1372
-
-
Patrignani, P.1
Filabozzi, P.2
Patrono, C.3
-
17
-
-
84867817838
-
Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival
-
Liao X, Lochhead P, Nishihara R, et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med. 2012;367(17):1596-1606.
-
(2012)
N Engl J Med.
, vol.367
, Issue.17
, pp. 1596-1606
-
-
Liao, X.1
Lochhead, P.2
Nishihara, R.3
-
18
-
-
81255205399
-
Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis
-
Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20(5):576-590.
-
(2011)
Cancer Cell.
, vol.20
, Issue.5
, pp. 576-590
-
-
Labelle, M.1
Begum, S.2
Hynes, R.O.3
-
19
-
-
84855893130
-
Platelet-derived MHC class i confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells
-
Placke T, Örgel M, SchallerM, et al. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res. 2012;72(2):440-448.
-
(2012)
Cancer Res.
, vol.72
, Issue.2
, pp. 440-448
-
-
Placke, T.1
Örgel, M.2
Schaller, M.3
-
20
-
-
76749138150
-
The predictive value of HLA class i tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer
-
de Kruijf EM, van Nes JG, Sajet A, et al. The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer. Clin Cancer Res. 2010;16(4):1272-1280.
-
(2010)
Clin Cancer Res.
, vol.16
, Issue.4
, pp. 1272-1280
-
-
De Kruijf, E.M.1
Van Nes, J.G.2
Sajet, A.3
-
21
-
-
34247270377
-
HLA expression and cancer - 14th IHIWS immunohistochemistry quality control exercise exchange results
-
Chew SF, Kanaan C, Tait BD. HLA expression and cancer - 14th IHIWS immunohistochemistry quality control exercise exchange results. Tissue Antigens. 2007;69(suppl 1):248-251.
-
(2007)
Tissue Antigens.
, vol.69
, Issue.SUPPL. 1
, pp. 248-251
-
-
Chew, S.F.1
Kanaan, C.2
Tait, B.D.3
-
22
-
-
0036083347
-
Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus
-
Buskens CJ, Van Rees BP, Sivula A, et al. Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology. 2002;122(7):1800-1807.
-
(2002)
Gastroenterology.
, vol.122
, Issue.7
, pp. 1800-1807
-
-
Buskens, C.J.1
Van Rees, B.P.2
Sivula, A.3
-
23
-
-
10744232899
-
Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer
-
de Jong AE, van Puijenbroek M, Hendriks Y, et al.Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res. 2004;10(3):972-980.
-
(2004)
Clin Cancer Res.
, vol.10
, Issue.3
, pp. 972-980
-
-
De Jong, A.E.1
Van Puijenbroek, M.2
Hendriks, Y.3
-
24
-
-
24144493178
-
Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome
-
Baudhuin LM, Burgart LJ, Leontovich O, Thibodeau SN. Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome. Fam Cancer. 2005;4(3):255-265.
-
(2005)
Fam Cancer.
, vol.4
, Issue.3
, pp. 255-265
-
-
Baudhuin, L.M.1
Burgart, L.J.2
Leontovich, O.3
Thibodeau, S.N.4
-
25
-
-
84870956218
-
Assessment of a fully automated high-throughput DNA extractionmethod from formalin-fixed, paraffin-embedded tissue for KRAS, and BRAF somatic mutation analysis
-
van Eijk R, Stevens L, Morreau H, vanWezel T. Assessment of a fully automated high-throughput DNA extractionmethod from formalin-fixed, paraffin-embedded tissue for KRAS, and BRAF somatic mutation analysis. Exp Mol Pathol. 2013;94(1):121-125.
-
(2013)
Exp Mol Pathol.
, vol.94
, Issue.1
, pp. 121-125
-
-
Van Eijk, R.1
Stevens, L.2
Morreau, H.3
Vanwezel, T.4
-
26
-
-
79952381358
-
Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR
-
van Eijk R, Licht J, Schrumpf M, et al. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR. PLoS One. 2011;6(3):e17791.
-
(2011)
PLoS One.
, vol.6
, Issue.3
-
-
Van Eijk, R.1
Licht, J.2
Schrumpf, M.3
-
28
-
-
27944441722
-
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class i expression correlates with a poor prognosis
-
Watson NF, Ramage JM, Madjd Z, et al. Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis. Int J Cancer. 2006;118(1):6-10.
-
(2006)
Int J Cancer.
, vol.118
, Issue.1
, pp. 6-10
-
-
Watson, N.F.1
Ramage, J.M.2
Madjd, Z.3
-
29
-
-
84866156209
-
Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma
-
Al-Maghrabi J, Buhmeida A, Emam E, et al. Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma.World J Gastroenterol. 2012;18(15):1793-1799.
-
(2012)
World J Gastroenterol
, vol.18
, Issue.15
, pp. 1793-1799
-
-
Al-Maghrabi, J.1
Buhmeida, A.2
Emam, E.3
-
30
-
-
84859840481
-
PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis
-
Fariña Sarasqueta A, Zeestraten EC, vanWezel T, et al. PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis. Cell Oncol (Dordr). 2011;34(6):523-531.
-
(2011)
Cell Oncol (Dordr).
, vol.34
, Issue.6
, pp. 523-531
-
-
Fariña Sarasqueta, A.1
Zeestraten, E.C.2
Vanwezel, T.3
-
31
-
-
84892843686
-
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer
-
Domingo E, Church DN, Sieber O, et al. Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer. J Clin Oncol. 2013;31(34):4297-4305.
-
(2013)
J Clin Oncol.
, vol.31
, Issue.34
, pp. 4297-4305
-
-
Domingo, E.1
Church, D.N.2
Sieber, O.3
-
32
-
-
84876954094
-
Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis
-
Akalay I, Janji B, HasmimM, et al. Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. Cancer Res. 2013;73(8):2418-2427.
-
(2013)
Cancer Res.
, vol.73
, Issue.8
, pp. 2418-2427
-
-
Akalay, I.1
Janji, B.2
Hasmim, M.3
-
33
-
-
82955212867
-
COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin
-
HolmesMD, ChenWY, Schnitt SJ, et al. COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. Breast Cancer Res Treat. 2011;130(2):657-662.
-
(2011)
Breast Cancer Res Treat.
, vol.130
, Issue.2
, pp. 657-662
-
-
Holmes, M.D.1
Chen, W.Y.2
Schnitt, S.J.3
-
34
-
-
84885183806
-
Low-dose aspirin use and cancer characteristics: A population-based cohort study
-
Jonsson F, Yin L, Lundholm C, Smedby KE, Czene K, Pawitan Y. Low-dose aspirin use and cancer characteristics: a population-based cohort study. Br J Cancer. 2013;109(7):1921-1925.
-
(2013)
Br J Cancer.
, vol.109
, Issue.7
, pp. 1921-1925
-
-
Jonsson, F.1
Yin, L.2
Lundholm, C.3
Smedby, K.E.4
Czene, K.5
Pawitan, Y.6
-
35
-
-
84879395305
-
Aspirin use and risk of colorectal cancer according to BRAF mutation status
-
Nishihara R, Lochhead P, Kuchiba A, et al. Aspirin use and risk of colorectal cancer according to BRAF mutation status. JAMA. 2013;309(24): 2563-2571.
-
(2013)
JAMA
, vol.309
, Issue.24
, pp. 2563-2571
-
-
Nishihara, R.1
Lochhead, P.2
Kuchiba, A.3
-
36
-
-
34548781961
-
Using prescription claims data for drugs available over-the-counter (OTC)
-
Yood MU, Campbell UB, Rothman KJ, et al. Using prescription claims data for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Saf. 2007;16(9):961-968.
-
(2007)
Pharmacoepidemiol Drug Saf.
, vol.16
, Issue.9
, pp. 961-968
-
-
Yood, M.U.1
Campbell, U.B.2
Rothman, K.J.3
|